Table 3 Statistically significant biological pathways affected by differentially expressed TGs in breast cancer cells identified from the KEGG database using DAVID
KEGG ID | Description | # Genes | P-Value |
|---|---|---|---|
hsa05200 | Pathways in cancer | 69 | 5.51E-08 |
hsa04350 | TGF-beta signaling pathway | 24 | 3.61E-05 |
hsa04010 | MAPK signaling pathway | 51 | 6.72E-05 |
hsa04310 | Wnt signaling pathway | 31 | 7.22E-04 |
hsa04110 | Cell cycle | 25 | 0.003827 |
hsa04330 | Notch signaling pathway | 11 | 0.027579 |
hsa04662 | B cell receptor signaling pathway | 15 | 0.030166 |
hsa04910 | Insulin signaling pathway | 23 | 0.034331 |
hsa04660 | T cell receptor signaling pathway | 19 | 0.043201 |
hsa04012 | ErbB signaling pathway | 16 | 0.047711 |